Rewarding top achievers for their
contributions in 2019
BIOSPECTRUM EXCELLENCE
AWARDS
2020
COMING SOON !
For more information on Nominations & Sponsorship Packages please contact
Ankit Kankar Saradha Mani
Manager- Product & Marketing Communication General Manager
Email : [email protected] Email : [email protected]
Mob : (Singapore) +65-83094128 Mob : (Singapore) +65-63369142
www.biospectrumasia.com www.biospectrumindia.com
The words you are searching are inside this book. To get more targeted content, please make full-text search by clicking here.
Needs much more for world without diabetes
Diabetes is on the rise across the globe as reported in the most recent 8th edition of the International Diabetes Federation (IDF) Diabetes Atlas 2017. As Diabetes is a lifestyle disease, it can be prevented by adopting appropriate lifestyle. This is what the evidence from studies conducted in the USA, Finland, China, India and Japan have proved. However, the pharma industry has been investing on R&D and launching new products but needs much more. From January 2019 to October 31, 2019, the US FDA has approved three products for type 2 diabetes (two drugs Rybelsus and Victoza from Novo Nordisk and one drug – Farxiga from AstraZeneca).
Discover the best professional documents and content resources in AnyFlip Document Base.
Search